Evidence map›Paper›PMID 42453354›Full record

ReviewACS pharmacology & translational science2026

Spore-Forming Probiotic-Embedded Biomaterials for Targeted Gut Microplastic Biodegradation.

George Michael Nicolas, Tianying Yuan, Andriansjah Rukmana, Zheng Zhang, Ruirui Qiao, Shaohua Ma

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

George Michael NicolasInstitute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China.
Tianying YuanInstitute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China.
Andriansjah RukmanaDepartment of Microbiology, Faculty of Medicine, Universitas Indonesia, Jakarta 16424, Indonesia.
Zheng ZhangInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen China.
Ruirui QiaoAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID https://orcid.org/0000-0002-8351-7093
Shaohua MaInstitute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China.ORCID https://orcid.org/0000-0002-4995-2032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microplastic (MP) exposure compromises gut barrier integrity, microbial homeostasis, and host immunity to accelerate mucosal dysfunction and disease progression. This necessitates new strategies to address gut MP accumulation concerns. Unlike environmental settings, the gut imposes harsh physiological constraints that restrict conventional plastic biodegradation mechanism feasibility. Spore-forming probiotic (SFP) strains possess intrinsic resilience and diverse plastic degradation metabolic capacities

Indexed as

biodegradationgut microbiota remediationmicroplasticsprobiotic-embedded biomaterialsspore-forming probiotics

Identifiers

PMID42453354
PMCPMC13366332

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.